RP-HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-01-27. Numbers and descriptions here follow the published literature rather than marketing material.
Handling and storage influence measured purity, and peptides can oxidize, deamidate, aggregate, or adsorb to surfaces over time. Lyophilized powders stored at -20 °C or lower are generally more stable than solutions, though some sequences require different conditions. Repeated freeze-thaw cycles can promote aggregation and loss, so testing after storage checks whether purity has changed. Stability-indicating methods compare stressed and unstressed samples to detect degradation pathways. Light exposure and pH can also accelerate modification.
Solid-phase peptide synthesis can produce truncated sequences when coupling reactions fail. Deletion peptides lack one or more internal residues, while truncation peptides end prematurely. Side reactions include aspartimide formation, oxidation of methionine, and aggregation during chain assembly. Crude synthetic peptides therefore contain target peptide plus related impurities, counterions, residual solvents, and water. Purification by preparative chromatography reduces these impurities but does not remove every closely related species, including some that differ by a single amino acid.
Quality control specifications for peptides typically include appearance, identity, purity by RP-HPLC, water content, counterion content, and residual trifluoroacetic acid. Karl Fischer titration measures water, while ion chromatography or elemental analysis can quantify counterions. Purity specifications may be set at 95% or 98% area percent, but the appropriate threshold depends on the application. For research reagents, a lower purity may be acceptable if identity is confirmed. For assays sensitive to impurities, higher purity and orthogonal testing are often required.
Handling practices reduce the risk of contamination and degradation. Hygroscopic peptides should be equilibrated to room temperature before opening to prevent condensation on the powder. Weighing and reconstitution in a controlled environment limit exposure to moisture and airborne particles. Aliquotting reconstituted solutions avoids repeated freeze-thaw cycles that can cause aggregation or precipitation. When a purity specification is not met, investigation may consider synthesis byproducts, purification losses, storage conditions, and analytical variability rather than a single cause.
Peptide purity can change during storage, handling, and reconstitution, and lyophilized peptides are generally more stable than solutions because water promotes hydrolysis and aggregation. Residual moisture, oxygen, and trace metals can accelerate degradation even in solid form. Temperature fluctuations during shipping may cause condensation and local moisture uptake. Quality control therefore includes appearance, water content, and analytical testing before and after storage challenges. Peptides containing cysteine, methionine, or tryptophan are especially susceptible to oxidation, while asparagine and glutamine residues can deamidate under neutral or alkaline conditions.
| Property | Value | Notes |
|---|---|---|
| Typical purity specification | ≥95% by RP-HPLC | Common for research-grade material; some assays require 98% or higher. |
| Water content | 5–10% w/w | Lyophilized peptides retain moisture; Karl Fischer titration measures it. |
| Counterion | Trifluoroacetate or acetate | Counterion identity affects mass balance and assay compatibility. |
| Storage temperature | -20 °C or lower | Store desiccated and protected from light; avoid repeated freeze-thaw. |
| Common impurity | Deletion or truncation peptide | Similar sequence complicates chromatographic separation. |
Sampling and sample preparation influence measured purity. Peptides are often hygroscopic, so weighing should occur quickly under controlled humidity to avoid water uptake. Complete dissolution in a suitable solvent is necessary before injection; undissolved material can block columns or distort results. Filtration removes particulates but may also remove aggregates if the filter pore size is too small. Impurities can originate from synthesis, cleavage, purification, or storage, and forced degradation under heat, light, oxidation, or pH extremes can help identify degradation pathways.
Regulatory and accreditation expectations depend on the peptide's intended use. Research reagents may be tested with in-house methods, while pharmaceutical development follows validated procedures and pharmacopeial chapters where applicable. Method validation commonly examines accuracy, precision, specificity, linearity, range, and limits of detection and quantitation. Laboratories accredited to ISO/IEC 17025 must document competence, equipment calibration, and uncertainty. Comparing purity results across laboratories remains difficult because different columns, gradients, detection wavelengths, and integration rules can change reported values; open questions include how best to standardize impurity identification and reporting for diverse peptide products.
Quality control for peptides places purity testing within a documented system that includes specifications, test methods, and acceptance criteria. A certificate of analysis typically reports appearance, chromatographic purity, mass confirmation, and storage conditions. System suitability checks, blank injections, and reference standards help ensure that an analytical run is valid. Traceability requires records of sample preparation, instrument settings, and data processing. No single purity threshold applies to all peptides or uses, so specifications are set according to the intended application and risk assessment.
Reverse-phase high-performance liquid chromatography (RP-HPLC) is widely used to estimate peptide purity. It separates components by hydrophobicity on a column with a water-organic mobile phase. Ultraviolet absorbance at 214 nm or 220 nm detects peptide bonds. The main peak area as a percentage of total peak area gives a purity figure. This figure depends on column, gradient, wavelength, and how peaks are integrated, so it is method-specific rather than absolute.
Mass spectrometry provides complementary information by measuring molecular mass. Electrospray ionization or matrix-assisted laser desorption/ionization can confirm the expected peptide mass and reveal related impurities with different masses. It does not directly quantify all species because ionization efficiency varies. When coupled to liquid chromatography, LC-MS can assign masses to chromatographic peaks. This helps distinguish target peptide from truncation, oxidation, or deletion products. Mass accuracy and resolution determine how confidently a mass can be matched to a proposed structure.
Banauch D, Brümmer W, Ebeling W, Metz H, Rindfrey H, Lang H, Leybold K, Rick W, Staudinger HJ (1975). "[A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]". Z. Klin. Chem. Klin. Biochem. 13 (3): 101–7. PMID 810982. Brink NG; Miettinen, Jorma K.; Olsen, John; Virtanen, Artturi I.; Sörensen, Nils Andreas (1953). "Beef liver glucose dehydrogenase. 1. Purification and properties". Acta Chem. Scand. 7: 1081–1089. doi:10.3891/acta.chem.scand.07-1081. Pauly HE, Pfleiderer G (1976). "D-Glucose dehydrogenase from Bacillus megaterium M 1286: purification, properties and structure". Hoppe-Seyler's Z. Physiol. Chem. 356 (10): 1613–1623. doi:10.1515/bchm2.1975.356.2.1613. PMID 2530. Strecker HJ, Korkes S (1952). "Glucose dehydrogenase". J. Biol. Chem. 196 (2): 769–84. doi:10.1016/S0021-9258(19)52408-5. PMID 12981017. Thompson RE, Carper WR (1970). "Glucose dehydrogenase from pig liver. I. Isolation and purification". Biochim. Biophys. Acta. 198 (3): 397–406. doi:10.1016/0005-2744(70)90118-x. PMID 4392298.
Peripheral membrane proteins may interact with other proteins or directly with the lipid bilayer. In the latter case, they are then known as amphitropic proteins. Some proteins, such as G-proteins and certain protein kinases, interact with transmembrane proteins and the lipid bilayer simultaneously. Some polypeptide hormones, antimicrobial peptides, and neurotoxins accumulate at the membrane surface prior to locating and interacting with their cell surface receptor targets, which may themselves be peripheral membrane proteins. The phospholipid bilayer that forms the cell surface membrane consists of a hydrophobic inner core region sandwiched between two regions of hydrophilicity, one at the inner surface and one at the outer surface of the cell membrane (see lipid bilayer article for a more detailed structural description of the cell membrane). The inner and outer surfaces, or interfacial regions, of model phospholipid bilayers have been shown to have a thickness of around 8 to 10 Å, although this may be wider in biological membranes that include large amounts of gangliosides or lipopolysaccharides. The hydrophobic inner core region of typical biological membranes may have a thickness of around 27 to 32 Å, as estimated by Small angle X-ray scattering (SAXS). The boundary region between the hydrophobic inner core and the hydrophilic interfacial regions is very narrow, at around 3 Å, (see lipid bilayer article for a description of its component chemical groups).
Mostly containing a +5 species, which was immediately assigned to dubnium, it also had a +4 species; based on that result, the team decided that additional chemical separation was needed. In 2005, the experiment was repeated, with the final product being hydroxide rather than nitrate precipitate, which was processed further in both Livermore (based on reverse phase chromatography) and Dubna (based on anion exchange chromatography). The +5 species was effectively isolated; dubnium appeared three times in tantalum-only fractions and never in niobium-only fractions. It was noted that these experiments were insufficient to draw conclusions about the general chemical profile of dubnium. In 2009, at the JAEA tandem accelerator in Japan, dubnium was processed in nitric and hydrofluoric acid solution, at concentrations where niobium forms NbOF−4 and tantalum forms TaF−6. Dubnium's behavior was close to that of niobium but not tantalum; it was thus deduced that dubnium formed DbOF−4. From the available information, it was concluded that dubnium often behaved like niobium, sometimes like protactinium, but rarely like tantalum. In 2021, the volatile heavy group 5 oxychlorides MOCl3 (M = Nb, Ta, Db) were experimentally studied at the JAEA tandem accelerator. The trend in volatilities was found to be NbOCl3 > TaOCl3 ≥ DbOCl3, so that dubnium behaves in line with periodic trends.
Venezuela holds the world's largest proven oil reserves, estimated at 17% of the global total, or 300 billion barrels. In December 2025, the US began a maritime blockade of sanctioned oil or shadow fleet tankers. The 2025–2026 operations are seen by the Trump administration as serving the triple goals of crippling Maduro, disrupting drug trade routes, and getting access to Venezuelan oil; Trump stated that revenue generated would go to the Venezuelan people, US oil companies, and "to the United States of America in the form of reimbursement for the damages caused us by that country". Following the raid, Trump's press conference made clear that oil was a motivation for action in Venezuela. Citing the restructuring of Venezuela's oil industry in 1976 and 2007, Trump, Stephen Miller, and others claimed that Venezuela had stolen oil from US companies. Trump suggested on 5 January that seized oil could be treated as a US asset, asserting the willingness to sell it or add it to the US Strategic Petroleum Reserve. On 9 January, after other sanctioned vessels were seized, and a tanker was returned to Venezuela as part of a joint operation between interim authorities in Venezuela and the US, Trump said: "This tanker is now on its way back to Venezuela, and the oil will be sold through the GREAT Energy Deal, which we have created for such sales." The Trump administration also expressed interest in Venezuela's large deposits of gold and rare earth minerals.
Significant efforts in the mid-20th century helped clarify its nomenclature, stabilising its current name. Although there were challenges to this name in the 1980s, it was confirmed as valid in 2004. More recently, DNA studies suggest that there may be hidden diversity within the species, indicating the need for further taxonomic evaluation. The lichen is used as a spice in Indian cuisine. For this purpose, it is commonly known as black stone flower or kalpasi (among other names). Although nearly tasteless on its own, it releases an earthy fragrance and taste when cooked in with oil or butter.
Sources: en.wikipedia.org
== Pharmacology == Valsartan is an angiotensin II receptor blocker this class of drug competes with angiotensin II for the angiotensin type I (AT1) receptors located throughout the body. Angiotensin II is a key component of the renin-angiotensin-aldosterone system which is responsible for vasoconstriction of blood vessels and promotes release of vasopressin from the posterior pituitary gland of the hypothalamus which helps promote water retention. Aldosterone is also released by the adrenal gland in response to angiotensin II which helps to reabsorb sodium which leads to water reabsorption that results in a rise in blood pressure. Blocking angiotensin II from binding to AT1 receptors will in turn prevent it from raising blood pressure which is why angiotensin II receptor blockers are useful medications in the treatment of blood pressure. Hydrochlorothiazide inhibits the NaCl co-transporters in the distal convoluted tubule of the nephrons located in the kidneys which are responsible for the excretion of sodium and chloride in exchange for reabsorption of calcium. Inhibition of the NaCl co-transporters result in water excretion which is believed to be the mechanism of action in diuresis and lowering blood pressure.
== Further reading == Martin, C. (2003). The Wilderness Chef: Gourmet Recipes for the Great Outdoors. Lyons Press Series. Globe Pequot Press. pp. 162–163. ISBN 978-1-58574-858-7. "Massey scientists' bean chips could be next big health snack". Manawatu Standard. April 3, 2015. Retrieved April 28, 2015.
On May 27, 2014, Mister Donut collaborated with the Japanese fast food franchise Mos Burger on the MOSDO!, a burger using "a spiral-shaped chorizo, lettuce and spicy chili sauce sandwiched between Mister Donut's French Cruller donut as the buns." The menu item was released at Mos Burger stores, while Mister Donut stores at the time were selling "Mos Burger's famous rice burger with sweet bean paste, sweet potato paste, and custard cream stuffing." In April 2015, Mister Donut released new items such as the "Brooklyn Merry-Go-Round, which uses both cookie and bagel dough." At the time, the company announced that it would "launch new key products quarterly while maintaining its standard menu." In 2015, Japan revealed a summer doughnut menu themed to Brooklyn, New York. Japan Times explained that the menu was "'Brooklyn themed' in the sense it combines several foodstuffs into one, in the style of New York-born fusion treats such as the Cronut." Items included "berry or lemon doughnuts cut in half, with a layer of yogurt added to the middle, or a chocolate option with sugary cream in the center." As of May 2016, "some 80% of the menu at Mister Donut bakery and cafe is made up of coffee drinks and the rest is doughnuts." In Japan, current items as of July 2016 may include the old-fashioned doughnuts covered in chocolate or cinnamon-flavored. There is also a "chocolate almond croissant muffin," a salty donut, a chocolate-covered churro, a financier donut, and a Japanese-style matcha kuromitsu stick.
==== Distribution ==== Sumatriptan is a relatively hydrophilic molecule, which may limit its ability to cross the blood–brain barrier and enter the central nervous system. In accordance, early animal studies found lack of indication of central penetration by sumatriptan. This was in contrast to more lipophilic triptans like zolmitriptan, naratriptan, rizatriptan, and eletriptan. For these reasons, it was thought for many years that sumatriptan could not cross the blood–brain barrier in significant amounts to exert central effects. However, in subsequent animal studies, sumatriptan was found to enter the brain and produce centrally mediated effects. Besides animal research, clinical studies have found sumatriptan to produce centrally mediated side effects such as sleepiness, tiredness, thinking difficulty, and dizziness, among others. In addition, sumatriptan has been found to be discernibly psychoactive in human drug discrimination tests, with effects like apathy, sedation, and mild dysphoria. Certain other clinical findings also support centrally mediated effects of sumatriptan. A 2010 literature review concluded that sumatriptan can enter the brain to some minor extent in both animals and humans but that this minor penetration is nonetheless sufficient to cause pharmacological effects. Subsequent research has found sumatriptan given during migraine attacks decreases brain serotonin 5-HT1B receptor binding in humans, with a corresponding receptor occupancy of 16%.
Sources: en.wikipedia.org
No. Purity testing measures chemical composition and does not assess biological activity, sterility, or endotoxin levels. Functional performance must be tested in the intended assay.
Water adds mass and can affect concentration calculations. A peptide labeled 95% pure may contain water and counterions that reduce the actual peptide content.
Identity can be checked by mass spectrometry, and purity by RP-HPLC. Store according to supplier instructions and retest if experimental performance changes.
Most lyophilized peptides are stored desiccated at -20 °C or lower, protected from light. Some sequences require -80 °C for long-term stability. Storage recommendations depend on sequence, moisture content, and expected duration.